These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 9637526)

  • 1. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.
    Milligan GN; Bernstein DI; Bourne N
    J Immunol; 1998 Jun; 160(12):6093-100. PubMed ID: 9637526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
    Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
    Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
    Milligan GN; Bernstein DI
    Virology; 1995 Oct; 212(2):481-9. PubMed ID: 7571418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice.
    Parr MB; Parr EL
    Virology; 1999 Jun; 258(2):282-94. PubMed ID: 10366565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of genital T cell responses to herpes simplex virus type 2 resulting from immunization of the nasal mucosa.
    Milligan GN; Dudley-McClain KL; Chu CF; Young CG
    Virology; 2004 Jan; 318(2):507-15. PubMed ID: 14972519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract.
    Milligan GN; Bernstein DI
    Virology; 1997 Mar; 229(1):259-68. PubMed ID: 9123869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice.
    Milligan GN; Dudley-McClain KL; Young CG; Chu CF
    J Reprod Immunol; 2004 Apr; 61(2):115-27. PubMed ID: 15063634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LFA-3 plasmid DNA enhances Ag-specific humoral- and cellular-mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells in protection.
    Sin JI; Kim J; Dang K; Lee D; Pachuk C; Satishchandran C; Weiner DB
    Cell Immunol; 2000 Jul; 203(1):19-28. PubMed ID: 10915558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
    Gill N; Rosenthal KL; Ashkar AA
    J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune protection against HSV-2 in B-cell-deficient mice.
    Dudley KL; Bourne N; Milligan GN
    Virology; 2000 May; 270(2):454-63. PubMed ID: 10793004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2.
    Milligan GN
    J Virol; 1999 Aug; 73(8):6380-6. PubMed ID: 10400730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
    J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract.
    Gallichan WS; Rosenthal KL
    Virology; 1996 Oct; 224(2):487-97. PubMed ID: 8874509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice.
    Tengvall S; Harandi AM
    J Reprod Immunol; 2008 Jun; 78(1):49-57. PubMed ID: 17945349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
    Smith PM; Wolcott RM; Chervenak R; Jennings SR
    Virology; 1994 Jul; 202(1):76-88. PubMed ID: 7912023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
    Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
    Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravaginal infection with herpes simplex virus type-2 (HSV-2) generates a functional effector memory T cell population that persists in the murine genital tract.
    Tang VA; Rosenthal KL
    J Reprod Immunol; 2010 Dec; 87(1-2):39-44. PubMed ID: 20688399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive immune responses fail to provide protection against genital HSV-2 infection in the absence of IL-15.
    Gill N; Ashkar AA
    Eur J Immunol; 2007 Sep; 37(9):2529-38. PubMed ID: 17668897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Either a CD4(+)or CD8(+)T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice.
    Ghiasi H; Perng G; Nesburn AB; Wechsler SL
    Microb Pathog; 1999 Dec; 27(6):387-94. PubMed ID: 10588911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.